For instance, c.275G>C (p.Trp92Ser) variant has been reported in severe SMA type I patients with 3 SMN2 copies and a reduced interaction with SMN target proteins has been shown using a protein binding assay [46,47,48]. Here, SMN2 is linked to spinal muscular atrophy, type 1.